# MedIntel Phase 8 Technical Acceptance and Readiness Report

**Project:** MedIntel
**Scope:** Respiratory clinical decision-support research prototype
**Phase:** 8 - Integrated technical readiness and freeze
**Date:** 2026-08-11
**Freeze tag:** `medintel-phase8-readiness-freeze`

---

## 1. Status

Phase 8 technical readiness work is complete.

The final acceptance statement, effective at the Phase 8 freeze tag, is:

> MedIntel is a technically frozen, safety-hardened respiratory clinical decision-support research prototype that has passed its integrated technical acceptance tests. It is not clinically validated, does not autonomously establish a diagnosis or prescription, and requires the doctor to make the final clinical decision.

This statement is intentionally limited to engineering and technical acceptance.

It does **not** establish:

- clinical efficacy,
- diagnostic validity,
- treatment efficacy,
- regulatory approval,
- hospital-production readiness,
- medical-device certification,
- or autonomous clinical decision-making capability.

---

## 2. Frozen lineage

### Phase 6 technical prototype freeze

Tag:

`medintel-phase6-prototype-freeze`

Commit:

`388d847bdd7a9f3377c77beb019eac242ffc43c1`

Phase 6 established the technically integrated respiratory clinical decision-support research prototype.

### Phase 7 Track-A reporting freeze

Tag:

`medintel-phase7-track-a-reporting-freeze`

Commit:

`f39877a250aa1a5c3aeb1b08994b35ef6d120ad3`

Phase 7 Track-A reporting was frozen without claiming clinical validation.

Known Phase 7 limitation:

- Track-A item 7.5F remained incomplete.
- A5 remained `NOT_ASSESSED`.
- Clinical validation remained `NO`.

These limitations remain explicitly carried forward.

---

## 3. Phase 8 lineage

Key Phase 8 commits:

- `a98ffe5c8c19e6c02481db95277db75fd640e3aa` - assessment-to-workflow frontend integration.
- `c791b3829bb06b6b8b0d499f828ceccceb553f1e` - runtime hardening and local clinician authentication boundary.
- `9cd75c9f98e6754613ae8eb5ae3c0c0d7e7e5d82` - deployment hardening and CI gate.
- `f0cf05ac82622d1f48026630870f69f73774860c` - clean-runner CI correction.
- `948e9a84f134b90ef48f86ffa56d8edcac4f6645` - controlled reconciliation of parallel `main` history while preserving the accepted Phase 8 readiness tree.

The final documentation commit is the commit targeted by the Phase 8 freeze tag.

---

## 4. Phase 8.1 - Baseline and environment audit

Status: **PASS**

The frozen Phase 6 and Phase 7 lineage was preserved.

Readiness work was bounded to technical integration, safety hardening, authentication, deployment, reliability, CI, demonstration acceptance, and freeze preparation.

No model retraining or clinical-validation claim was introduced.

---

## 5. Phase 8.2 - Full workflow acceptance

Status: **PASS**

A complete clinician-facing assessment-to-workflow path was integrated.

One live full workflow verification completed with:

- HTTP status `200`,
- approximately `471.1 s` end-to-end execution,
- live reasoning-provider invocation,
- safe degradation when the reasoning parser could not accept the provider response.

The safe degradation preserved the authoritative differential-diagnosis structure.

This live execution was an engineering verification using synthetic research input. It was **not clinical validation**.

No additional model rerun was required during the later readiness phases.

---

## 6. Phase 8.3 - Failure, degraded-mode, and safety acceptance

Status: **PASS**

A targeted zero-network safety/failure regression battery completed:

`56 / 56 PASS`

Coverage included degraded and safety-sensitive execution behavior.

This targeted Phase 8.3 regression battery is separate from the later minimal GitHub CI workflow.

The GitHub CI gate must not be interpreted as replacing the broader Phase 8.3 safety regression work.

---

## 7. Phase 8.4 - Authentication and security boundary

Status: **PASS for the bounded research-prototype scope**

Implemented:

- local single-clinician username/password authentication,
- JWT Bearer authentication,
- protected clinical API routers,
- public health endpoint,
- fail-closed runtime secret configuration,
- ignored local `.env`,
- browser `sessionStorage` clinician session,
- loopback-only host exposure for the clinician UI and backend,
- no database host-port exposure,
- no direct MedGemma host-port exposure.

This is a **local research-prototype authentication boundary**.

It is **not production IAM** and does not establish hospital-grade identity, auditing, authorization governance, regulatory compliance, or enterprise access control.

---

## 8. Phase 8.5 - Deployment and reliability readiness

Status: **PASS for the bounded technical-readiness scope**

Deployment hardening includes:

- production Nginx frontend runtime,
- SPA fallback routing,
- `/api/` and `/health` reverse proxying,
- digest-pinned container base references used in the accepted deployment configuration,
- digest-pinned PostgreSQL image,
- explicit database/backend/frontend healthchecks,
- restart policies,
- dependency health gating,
- loopback-only frontend/backend host bindings,
- persistent PostgreSQL volume preservation,
- backend restart-recovery verification,
- frontend restart-recovery verification,
- minimal GitHub Actions CI gate.

The CI gate performs:

- backend dependency installation,
- backend source compilation,
- authentication regression testing,
- frontend linting,
- frontend production build,
- Docker Compose configuration validation,
- production frontend-container build.

This CI is an engineering gate. It is **not a clinical-validation system**.

No arbitrary model resource-limit values were introduced merely to satisfy a deployment checklist.

Phase 8 does not claim hospital-production deployment certification.

---

## 9. Phase 8.6 - Final acceptance and reconciliation

### Remote CI repair

The first clean-runner CI attempt exposed CI-environment defects rather than model or runtime defects.

The corrected CI commit:

`f0cf05ac82622d1f48026630870f69f73774860c`

passed all required jobs:

- Backend validation - PASS
- Frontend validation - PASS
- Deployment configuration - PASS

### Parallel-main reconciliation

`main` contained parallel older development commits that conflicted with five accepted Phase 8 files.

The conflicting versions were not blindly merged.

A controlled history reconciliation was created at:

`948e9a84f134b90ef48f86ffa56d8edcac4f6645`

with:

- readiness commit as first parent,
- prior `main` commit as second parent,
- the accepted Phase 8 readiness tree preserved exactly,
- no imported unvalidated parallel source changes.

Tree identity before and after reconciliation was identical.

Remote CI passed again after reconciliation.

---

## 10. Runtime preservation at final readiness acceptance

At the final Phase 8 reconciliation gate:

- database - running / healthy,
- MedGemma - running / healthy,
- backend - running / healthy,
- frontend - running / healthy.

Result:

`4 / 4 healthy`

The frozen MedGemma runtime container remained:

`252f015e3a063c5bb6dfdc1e629330ea31de89498b824ea1c0f166b5561de47f`

No MedGemma inference was performed during the final readiness reconciliation and freeze-preparation checks.

---

## 11. Clinical and research limitations

The following limitations remain mandatory parts of the project interpretation:

1. The differential-diagnosis research workflow uses synthetic DDXPlus v6.2 research data.
2. The system is not clinically validated.
3. Phase 7 Track-A 7.5F remains incomplete.
4. A5 remains `NOT_ASSESSED`.
5. The doctor remains responsible for the final diagnosis, treatment, disposition, and clinical decision.
6. MedIntel does not autonomously prescribe.
7. MedIntel does not autonomously establish a diagnosis.
8. The local clinician authentication boundary is not production IAM.
9. Application-level production patient-data persistence, governance, audit, retention, and regulatory controls are not established by Phase 8.
10. Phase 8 technical acceptance does not establish hospital-production readiness.
11. The minimal GitHub CI gate does not replace safety evaluation, clinical validation, or regulatory assessment.
12. Safe reasoning-provider degradation observed during live engineering verification must not be interpreted as validated clinical reasoning performance.

---

## 12. Final technical acceptance

Phase 8 establishes an integrated engineering acceptance baseline suitable for continued controlled research and demonstration.

It supports:

- clinician-controlled structured assessment,
- authoritative XGBoost differential ranking,
- constrained MedGemma reasoning,
- safety validation,
- clinician authentication,
- production-style local frontend serving,
- health-gated container orchestration,
- CI-gated source validation,
- and reproducible technical freeze history.

It does not change the fundamental safety boundary:

**AI informs; the doctor decides.**

---

## 13. Freeze declaration

The Phase 8 freeze tag:

`medintel-phase8-readiness-freeze`

identifies the accepted Phase 8 technical-readiness baseline.

Future development must occur after this freeze and must not rewrite the frozen Phase 6, Phase 7, or Phase 8 histories.
